Don't give up on the FDA decission - it will come through eventually. It may depend on the label claim. The FDA may want a number of limitation on when In Tube can be used (e.g. age of subjects, only immunocompetent subjects, etc) rather and a broad label claim for all LTBI testing. This would severely reduce the size of the market so CST would be right to "discuss" this with the FDA. This could be a reason for the delays.
- Forums
- ASX - By Stock
- yoyo
Don't give up on the FDA decission - it will come through...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
|
|||||
Last
6.8¢ |
Change
-0.003(4.23%) |
Mkt cap ! $16.44M |
Open | High | Low | Value | Volume |
7.0¢ | 7.0¢ | 6.8¢ | $3.063K | 43.98K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 45450 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 2149 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 45450 | 0.066 |
1 | 13000 | 0.040 |
1 | 33366 | 0.030 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 2149 | 1 |
0.081 | 23638 | 1 |
0.082 | 29850 | 1 |
0.085 | 10000 | 1 |
0.090 | 250000 | 1 |
Last trade - 10.25am 15/08/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online